 Allergan Inc.'s advanced talks to acquire another drug maker drew the ire of activist investor William Ackman, the latest flare-up in one of the year's most contentious takeover battles.. Mr. Ackman, in conjunction with Valeant Pharmaceuticals International Inc., is trying to take over Allergan. But a resistant Allergan instead has plotted a takeover of its own and is in late-stage talks with North Carolina's Salix Pharmaceuticals Ltd., a move that could thwart Valeant's efforts.